Beta Bionics, Inc. (BBNX)
16.92
+1.22
(+7.80%)
USD |
NASDAQ |
Nov 09, 16:00
16.92
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics Total Assets (Quarterly) : 443.76M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 443.76M |
| June 30, 2026 | 292.39M |
| March 31, 2026 | 304.42M |
| December 31, 2025 | 328.74M |
| September 30, 2025 | 330.05M |
| June 30, 2025 | 329.97M |
| Date | Value |
|---|---|
| March 31, 2025 | 338.02M |
| December 31, 2024 | 149.64M |
| September 30, 2024 | 96.94M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 110.04M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp. | 473.76M |
| Edwards Lifesciences Corp. | 14.14B |
| Intuitive Surgical, Inc. | 19.35B |
| Stryker Corp. | 47.25B |
| Zimmer Biomet Holdings, Inc. | 23.54B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 42.38M |
| Shareholders Equity (Quarterly) | 401.38M |
| Debt to Equity Ratio | 0.0152 |
| Current Ratio | 8.922 |
| Net Debt Paydown Yield | 0.01% |